抗抗炎药单抗（Anti-Sarilumab/Kevzara,靶点IL-6R）

DetectionantibodyforBevacizumab,PK/PDbridgingELISAwithA01975-40

配对的抗配合型抗体，可用于SandwichELISA检测

Anti-PembrolizumabAntibody(10E12C6)[Biotin],mAb,Mouse

IC50(μg/ml)

Indirect/InhibitoryELISA,

A01848-40

CaptureantibodyforAdalimumabPK/PDbridgingELISAwithA01955-40

Anti-BevacizumabAntibody(6C3),mAb,Mouse

A01969-40

Anti-TocilizumabAntibody(14B10),mAb,Mouse

N/A

MonoRab™Anti-RituximabAntibody(194D7)[Biotin],mAb,Rabbit

0.118

Anti-RituximabAntibody(17B6),mAb,Mouse

0.175

A01948-40

A02030-40

A02042-40

DirectELISA,

产品编号

Anti-IpilimumabAntibody(4H6),mAb,Mouse

Non-inhibitory

抗伊匹单抗（Anti-Ipilimumab/Yervoy，靶点CTLA-4）

A01970-40

抗达雷木单抗（Anti-Daratumumab/Darzalex,靶点CD38）

Non-inhibitory

称呼

关注微信群众号

Anti-RanibizumabAntibody(6C3),mAb,Mouse

Anti-RituximabAntibody,pAb,Rabbit

抗德瓦鲁单抗（Anti-Durvalumab/Imfinzi,靶点CD274)

A01960-40

CaptureantibodyforBevacizumab,PK/PDbridgingELISAwithA01896-40

产品编号

Direct/IndirectELISA,

Indirect/InhibitoryELISA,

0.353

1.37

A01922-40

IndirectELISA,

IndirectELISA,

A01961-40

半抑制率IC50（µg/ml）

半抑制率

CaptureantibodyforRanibizumab,PK/PDbridgingELISAwithA02036-40

目录产品»

DirectELISA,

A01844-40

了解产品概略

Direct/InhibitoryELISA, 

抑制性或中和性

DetectionantibodyforIpilimumab,PK/PDbridgingELISAwithA01859-40

Direct/Indirect/InhibitoryELISA,

N/A

运用举荐

Anti-SarilumabAntibody(23H12),mAb,Mouse

抗派姆单抗（Anti-Pembrolizumab/Keytruda，靶点PD-1）

Non-inhibitory

产品编号

DetectionantibodyforIpilimumab,PK/PDbridgingELISAwithA01859-40

半抑制率

Anti-DurvalumabAntibody(4B5),mAb,Mouse

MonoRab™Anti-AdalimumabAntibody(134D5),mAb,Rabbit

A01918-40

Direct/IndirectELISA,

Anti-BevacizumabAntibody(6C3)[Biotin],mAb,Mouse

CaptureantibodyforBevacizumabPK/PDbridgingELISAwithA01976-40

N/A

Anti-DurvalumabAntibody,pAb,Rabbit

称呼

抗抗炎药单抗（Anti-Sarilumab/Kevzara,靶点IL-6R）

CaptureantibodyforObinutuzumabPK/PDbridgingELISAwithA01946-40

CaptureantibodyforIpilimumab,PK/PDbridgingELISAwithA01858-40

运用举荐

Anti-CetuximabAntibody(18D5),mAb,Mouse

A02044-40

半抑制率

  

DetectionantibodyforAdalimumab,PK/PDbridgingELISAwithA01954-40

Direct/IndirectELISA,

产品编号

MonoRab™Anti-RituximabAntibody(194D7),mAb,Rabbit

Anti-AtezolizumabAntibody(10G9),mAb,Mouse

N/A

运用举荐

称呼

运用举荐

Anti-NivolumabAntibody,pAb,Rabbit

N/A

A01896-40

一抗»

Direct/IndirectELISA,

称呼

Non-inhibitory

DetectionantibodyforTrastuzumab,PK/PDbridgingELISAwithA02032-40 

Immunogenicityassay

N/A

N/A

Anti-ObinutuzumabAntibody(18H8),mAb,Mouse

N/A

DetectionantibodyforDurvalumab,PK/PDbridgingELISAwithA02029-40

Non-inhibitory

运用举荐

  

半抑制率

Direct/InhibitoryELISA,

原理图

N/A

DetectionantibodyforAdalimumab,PK/PDbridgingELISAwithA01954-40

DirectELISA,Immunogenicityassay

IC50(μg/ml)

测试样品

A01947-40

Detectionantibodyforpembrolizumab,PK/PDbridgingELISAwithA01852

运用举荐

称呼

CaptureantibodyforNivolumab,PK/PDbridgingELISAwithA01848-40

MonoRab™Anti-PembrolizumabAntibody(90G12),mAb,Rabbit 

Anti-AdalimumabAntibody(3C2)[Biotin],mAb,Mouse

运用举荐

N/A

A01977-40

N/A

称呼

A02033-40

运用举荐

DetectionantibodyforTocilizumab,PK/PDbridgingELISAwithA01978-40

A01945-40

DirectELISA,

抗阿特朱单抗（Anti-Atezolizumab,靶点PD-L1）

IC50(μg/ml)

Direct/IndirectELISA,

0.046

MonoRab™兔抗Pembrolizumab单克隆抗体(克隆ID：90G12F8)（货号：A01853）亲和力

A01944-40

特性

称呼

Direct/InhibitoryELISA, 

MonoRab™Anti-BevacizumabAntibody(30E1),mAb,Rabbit

A01858-40

MonoRab™Anti-ObinutuzumabAntibody(169F10),mAb,Rabbit

Direct/IndirectELISA,

Non-inhibitory

A02043-40

A01853-40

A01923-40

0.118

产品编号

抗原阻断

特性

Direct/IndirectELISA,

产品编号

运用举荐

Anti-RituximabAntibody(17B6)[Biotin],mAb,Mouse

Anti-AdalimumabAntibody(15C7),mAb,Mouse

半抑制率

A01965-40

A01846-40

A01978-40

A01954-40

N/A

IndirectELISA,

A01938-40

Anti-AdalimumabAntibody(3C2),mAb,Mouse

IC50(μg/ml)

DetectionantibodyforAtezolizumab,PK/PDbridgingELISAwithA01948-40

抗雷珠单抗（Anti-Ranibizumab/Lucentis,靶点VEGF）

Immunogenicityassay

抗托株单抗（Anti-Tocilizumab，靶点TNF）

抗利妥昔单抗（Anti-Rituximab，靶点CD20）

0.582

DetectionantibodyforDaratumumab,PK/PDbridgingELISAwithA01996-40

产品编号

人的血清/血浆，小鼠的血清/血浆

A02036-40

Anti-NivolumabAntibody(8G6G3D8),mAb,Mouse

Anti-DurvalumabAntibody(15D6),mAb,Mouse

DetectionantibodyforNivolumab,PK/PDbridgingELISAwithA01847-40

Anti-InfliximabAntibody(27A4),mAb,Mouse

IC50(μg/ml)

DetectionantibodyforRituximab,PK/PDbridgingELISAwithA01942-40

N/A

A01949-40

DetectionantibodyforBevacizumab,PK/PDbridgingELISAwithA01975-40

称呼

运用

检测结合型和总量

Anti-AtezolizumabAntibody(6B12),mAb,Mouse

半抑制率

注册会员，在线提交订单，物流随时盘诘

MonoRab™Anti-AdalimumabAntibody(196F3),mAb,Rabbit

产品编号

用Biotin标记的小鼠抗Pembrolizumab单克隆抗体（A01845）作为检测抗体。）

0.017

A01859-40

运用举荐

抗达雷木单抗（Anti-Daratumumab/Darzalex,靶点CD38)

Non-inhibitory

Immunogenicityassay

运用

Anti-TocilizumabAntibody,pAb,Rabbit

CaptureantibodyforRituximab,PK/PDbridgingELISAwithA01970-40

Anti-IpilimumabAntibody(26B6H7D9),mAb,Mouse

抗贝伐单抗（Anti-Bevacizumab，靶点VEGF）

Immunogenicityassay

MonoRab™Anti-RituximabAntibody(137C6),mAb,Rabbit

IC50(μg/ml)

A01971-40

Non-inhibitory

MonoRab™Anti-AdalimumabAntibody(4E12),mAb,Rabbit

抗西妥昔单抗（Anti-Cetuximab，靶点EGFR）

CaptureantibodyforAdalimumabPK/PDbridgingELISAwithA01922-40

Non-inhibitory

N/A

Non-inhibitory

QQ：2885349184；qq:53309786

Anti-InfliximabAntibody(23H5),mAb,Mouse

IndirectELISA,

检测范围

产品选择辅导

MonoRab™Anti-ObinutuzumabAntibody(8G12),mAb,Rabbit

用兔抗Pembrolizumab多克隆抗体（A01846）作为阳性比拟，绘制标准曲线

N/A

Immunogenicityassay

Detectionantibodyforpembrolizumab,PK/PDbridgingELISAwithA01844

N/A

IC50(μg/ml)

Immunogenicityassay

称呼

IndirectELISA,

A01946-40

抗雷珠单抗（Anti-Ranibizumab/Lucentis,靶点VEGF)

0.37

Anti-DurvalumabAntibody(7B6),mAb,Mouse

A02010-40

Non-inhibitory

Anti-NivolumabAntibody(6G5),mAb,Mouse

MonoRab™Anti-PembrolizumabAntibody(90G12F8)[Biotin],mAb,Rabbit

抗英夫利昔单抗（Anti-Infliximab/Remicade,靶点TNF-α）

抗伊匹单抗（Anti-Ipilimumab，靶点CTLA-4）

半抑制率

A02040-40

CaptureantibodyforRituximab,PK/PDbridgingELISAwithA01943-40

DetectionantibodyforRituximab,PK/PDbridgingELISAwithA01969-40

Anti-IpilimumabAntibody(4H6E1D4)[Biotin],mAb,Mouse

Anti-SarilumabAntibody(26B10),mAb,Mouse

Anti-AtezolizumabAntibody(6B12)[Biotin],mAb,Mouse

抗体产品»

A01942-40

Direct/IndirectELISA,

免疫原性分析：配体中和实行和抗体阻断实行的比拟

Anti-DaratumumabAntibody(9A6),mAb,Mouse

抗纳武单抗（Anti-Nivolumab，靶点PD-1）

矫捷度

N/A

A01845-40

A02032-40

产品编号

N/A

IndirectELISA,

随着仿制药的出现，使得患者可以享用担负得起的创新药。GenScript消耗出种种典范的针对重磅药物的抗配合型抗体，助力仿制药的研发。

Non-inhibitory

Direct/IndirectELISA,

A02041-40

CaptureantibodyforObinutuzumabPK/PDbridgingELISAwithA01967-40

Anti-NivolumabAntibody(6G5H2E6)[Biotin],mAb,Mouse

Direct/InhibitoryELISA

N/A

抗德瓦鲁单抗（Anti-Durvalumab/Imfinzi,靶点CD274)

Anti-RituximabAntibody(6C1),mAb,Mouse

称呼

称呼

DirectELISA,

Indirect/InhibitoryELISA,

IC50(μg/ml)

0.258

抗西妥昔单抗（Anti-Cetuximab/Erbitux，靶点EGFR）

DetectionantibodyforObinutuzumab,PK/PDbridgingELISAwithA01945-40

A01980-40

IC50(μg/ml)

DetectionantibodyforRituximab,PK/PDbridgingELISAwithA01969-40

IC50(μg/ml)

N/A

CaptureantibodyforInfliximab,PK/PDbridgingELISAwithA02041-40

0.056

Immunogenicityassay

产品编号

CaptureantibodyforCetuximab,PK/PDbridgingELISAwithA01938-40

MonoRab™Anti-BevacizumabAntibody(46E3),mAb,Rabbit

A01975-40

抗配合型（Anti-idiotype）抗体

IC50(μg/ml)

Direct/InhibitoryELISA, 

Anti-TrastuzumabAntibody(15H2),mAb,Mouse

A01996-40

DetectionantibodyforCetuximab,PK/PDbridgingELISAwithA01939-40

DirectELISA,

Anti-TrastuzumabAntibody(11C4),mAb,Mouse

Anti-RanibizumabAntibody,pAb,Rabbit

wlueaznbc@sina.com；《产品订单提交模板》下载

A01931-40

0.85

半抑制率

DirectELISA,

Direct/Indirect/InhibitoryELISA,

Direct/IndirectELISA,

抗阿达木单抗（Anti-Adalimumab,靶点TNFα）

Non-inhibitory

Direct/IndirectELISA,

DetectionantibodyforObinutuzumab,PK/PDbridgingELISAwithA01966-40

Anti-TocilizumabAntibody(6C10),mAb,Mouse

产品编号

A01966-40

0.062

Indirect/InhibitoryELISA,

产品编号

产品编号

Non-inhibitory

无抑制性

Non-inhibitory

A01943-40

Anti-DaratumumabAntibody(11F2),mAb,Mouse

半抑制率

IC50(μg/ml)

DetectionantibodyforObinutuzumab,PK/PDbridgingELISAwithA01945-40

A02029-40

运用举荐

A01962-40

Non-inhibitory

0.04616

Direct/IndirectELISA,

1.56-100ng/ml

Direct/IndirectELISA,

Anti-BevacizumabAntibody,pAb,Rabbit

Anti-DaratumumabAntibody(6A3),mAb,Mouse

0.38

CaptureantibodyforTocilizumabPK/PDbridgingELISAwithA01979-40

半抑制率

测试样品

DetectionantibodyforAtezolizumab,PK/PDbridgingELISAwithA01948-40

Anti-BevacizumabAntibody(4H1),mAb,Mouse

CaptureantibodyforSarilumab,PK/PDbridgingELISAwithA02043-40

Direct/IndirectELISA,

检测范围

抗原结合性

非阻断

400-025-8686-5810/5256/5103

抗奥滨尤妥珠单抗（Anti-Obinutuzumab，靶点CD20）

A01979-40

检测游离型的抗体

Non-inhibitory

Direct/IndirectELISA,

N/A

抗托株单抗（Anti-Tocilizumab/Actemra，靶点IL-6R）

运用举荐

A01886-40

A02031-40

A02009-40

称呼

Direct/InhibitoryELISA, 

Direct/InhibitoryELISA

A01847-40

Direct/IndirectELISA,

  

DetectionantibodyforObinutuzumab,PK/PDbridgingELISAwithA01945-40

帕博利珠单抗（Pembrolizumab）的PK检测原理图（用小鼠抗Pembrolizumab单克隆抗体（A01844）作为捕获抗体，

Non-inhibitory

N/A

Direct/Indirect/InhibitoryELISA,

N/A

Anti-PembrolizumabAntibody,pAb,Rabbit

半抑制率

A01887-40

Immunogenicityassay

Anti-ObinutuzumabAntibody(16B7)[Biotin],mAb,Mouse

Direct/InhibitoryELISA,

Direct/IndirectELISA,

A01950-40

MonoRab™单克隆抗体检测矫捷度可达皮摩尔量级

半抑制率

抗利妥昔单抗（Anti-Rituximab/Rituxan，靶点CD20）

Direct/Indirect/InhibitoryELISA,

运用举荐

抗奥滨尤妥珠单抗（Anti-Obinutuzumab/Gazyva，靶点CD20）

称呼

抗体药物的药代动力学（PK）和药效动力学（PD）分析

称呼

Direct/IndirectELISA,

A01895-40

Non-inhibitory

人的血清/血浆（EDTA抗凝），小鼠的血清，大鼠血清/血浆（肝素抗凝），兔血清/血浆（肝素抗凝）

A01997-40

DetectionantibodyforRituximab,PK/PDbridgingELISAwithA01942-40

Direct/InhibitoryELISA

A01976-40

Direct/IndirectELISA,

Direct/IndirectELISA,

  

DetectionantibodyforTocilizumab,PK/PDbridgingELISAwithA01978-40

Anti-SarilumabAntibody(20F5),mAb,Mouse

A02037-40

N/A

DirectELISA,

IC50(μg/ml)

半抑制率

产品编号

A01968-40

Non-inhibitory

Immunogenicityassay

运用举荐

帕博利珠单抗（Pembrolizumab）用于生物仿制药免疫原性检测的原理图

抗英夫利昔单抗（Anti-Infliximab/Remicade,靶点TNF-α）

DetectionantibodyforObinutuzumab,PK/PDbridgingELISAwithA01966-40

0.295ng/ml

检测范围广，浓度结果精确

抗配合型抗体（Anti-idiotypeantibody,Anti-IDAbs）是针统一体可变区的抗原决定簇（配合型）发作的特异性抗体。抗配合型抗体被广泛用于临床前研讨和临床开拓中抗体药物含量的测定（包括：游离型、结合型和总量）。在医学研讨中，被用于疫苗及抗体药物的免疫原性（immunogenicity）分析。

Anti-TocilizumabAntibody(6C10)[Biotin],mAb,Mouse

DirectELISA,

Captureantibodyforpembrolizumab,PK/PDbridgingELISAwithA01845

DetectionantibodyforSarilumab,PK/PDbridgingELISAwithA02042-40 

抗阿特朱单抗（Anti-Atezolizumab/Tecentriq，靶点PD-L1）

A01967-40

DetectionantibodyforNivolumab,PK/PDbridgingELISAwithA01847-40

MonoRab™Anti-ObinutuzumabAntibody(169F10)[Biotin],mAb,Rabbit

Direct/IndirectELISA,

A01933-40

抗曲妥珠单抗（Anti-Trastuzumab/Herceptin,靶点HER2）

Anti-RanibizumabAntibody(10D12),mAb,Mouse

CaptureantibodyforAtezolizumabPK/PDbridgingELISAwithA01949-40

A01921-40

运用举荐

非抗体结合区特异性

A02035-40

Anti-ObinutuzumabAntibody(16B7),mAb,Mouse

IndirectELISA,

抗阿达木单抗（Anti-Adalimumab/Humira，靶点TNFα）

Kd

Direct/Indirect/InhibitoryELISA,

0.38

N/A

Direct/IndirectELISA,

产品编号

IndirectELISA,

抗体结合区特异性

Anti-PembrolizumabAntibody(1D6E10),mAb,Mouse

MonoRab™Anti-BevacizumabAntibody(46E3)[Biotin],mAb,Rabbit

A01955-40

DetectionantibodyforInfliximab,PK/PDbridgingELISAwithA02040-40

1.56-100ng/ml

称呼

产品编号

Detectionantibodyforpembrolizumab,PK/PDbridgingELISAwithA01852

Direct/IndirectELISA,

N/A

IndirectELISA,

抗曲妥珠单抗（Anti-Trastuzumab/Herceptin,靶点HER2)

N/A

典范

Anti-ObinutuzumabAntibody,pAb,Rabbit

Non-inhibitory

MonoRab™Anti-Daratumumab(139B10),mAb,Rabbit

Indirect/InhibitoryELISA,

半抑制率

Anti-CetuximabAntibody(20H1),mAb,Mouse

IC50(μg/ml)

抗纳武单抗（Anti-Nivolumab/Opdivo，靶点PD-1）

IC50(μg/ml)

抗配合型（Anti-idiotype）抗体

DetectionantibodyforAdalimumab,PK/PDbridgingELISAwithA01921-40

Direct/InhibitoryELISA, 

A01998-40

抗派姆单抗（Anti-Pembrolizumab，靶点PD-1）

Direct/IndirectELISA,

CaptureantibodyforTrastuzumab,PK/PDbridgingELISAwithA02033-40

Direct/IndirectELISA

Direct/IndirectELISA,

0.2073

运用举荐

抗贝伐单抗（Anti-Bevacizumab/Avastin，靶点VEGF）

CaptureantibodyforDurvalumab,PK/PDbridgingELISAwithA02030-40

DetectionantibodyforBevacizumab,PK/PDbridgingELISAwithA01895-40

DirectELISA,

Non-inhibitory

Anti-AdalimumabAntibody,pAb,Rabbit

0.20ng/ml

Non-inhibitory

DetectionantibodyforBevacizumab,PK/PDbridgingELISAwithA01895-40

称呼

Direct/IndirectELISA,

Direct/IndirectELISA,CaptureantibodyforDaratumumab,PK/PDbridgingELISAwithA01997-40

半抑制率

A01932-40

A01956-40

A01939-40

矫捷度